Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.

Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF; American Society of Clinical Oncology.

J Clin Oncol. 2010 Jul 10;28(20):3388-404. doi: 10.1200/JCO.2009.26.4481. Epub 2010 Jun 7.

PMID:
20530278
3.

Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.

Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG.

Oncol Rep. 1998 Nov-Dec;5(6):1425-9.

PMID:
9769381
4.

[Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].

Neumann A, Keller T, Jocham D, Doehn C.

Aktuelle Urol. 2011 Sep;42(5):311-5. doi: 10.1055/s-0031-1271545. Epub 2011 Aug 1. German.

PMID:
21809268
5.

Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.

Fosså A, Fosså SD.

Br J Urol. 1989 Apr;63(4):408-15.

PMID:
2653557
6.

Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.

Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.

Cancer. 2003 Oct 15;98(8):1635-42.

7.

Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?

Gerl A, Lamerz R, Clemm C, Mann K, Hartenstein R, Wilmanns W.

Clin Cancer Res. 1996 Sep;2(9):1565-70.

8.

Extragonadal germ cell tumors in Japan.

Ebi H, Nakata M, Tahara M, Igarashi T, Kawada K, Itoh K, Ueda R, Minami H.

Cancer Sci. 2003 Dec;94(12):1107-11.

9.

Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.

Otto T, Virchow S, Fuhrmann C, Steinberg F, Streffer C, Goepel M, Rübben H.

Urol Res. 1997;25(2):121-4.

PMID:
9144879
10.

[Systematic review 2007: Primary treatments of testicular germ cell tumors after radical orchydectomy].

Mottet N, Rousmans S, Culine S.

Bull Cancer. 2008 Feb;95(2):205-34. Review. French.

11.

The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.

Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH.

J Urol. 1996 Feb;155(2):587-9.

PMID:
8558665
12.

Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.

You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Fléchon A.

Urology. 2010 Aug;76(2):423-9.e2. doi: 10.1016/j.urology.2010.02.049. Epub 2010 May 15.

PMID:
20472276
13.

[Tumor markers in testicular cancer].

Mann K.

Urologe A. 1990 Mar;29(2):77-86. Review. German.

PMID:
2158684
14.

The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.

Weissbach L, Bussar-Maatz R, Mann K.

Eur Urol. 1997;32(1):16-22.

PMID:
9266226
15.

[Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].

Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.

Ai Zheng. 2008 Dec;27(12):1302-6. Chinese.

PMID:
19079998
16.

Serum markers in germ cell neoplasms.

Bartlett NL, Freiha FS, Torti FM.

Hematol Oncol Clin North Am. 1991 Dec;5(6):1245-60. Review.

PMID:
1723408
17.

Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.

Amato RJ, Ro JY, Ayala AG, Swanson DA.

Urology. 2004 Jan;63(1):144-8; discussion 148-9.

PMID:
14751368
18.

Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.

Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP.

J Clin Oncol. 2005 Sep 1;23(25):6149-56.

PMID:
16135481
19.

Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.

Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.

J Surg Oncol. 2006 Dec 1;94(7):619-23.

PMID:
17111392
20.

Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy.

Kundu SD, Carver BS, Sheinfeld J.

Urology. 2011 Oct;78(4):844-7. doi: 10.1016/j.urology.2011.02.002. Epub 2011 Jul 22.

Supplemental Content

Support Center